Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 13076 - 13100 of 13918 in total
MRK-409 is a GABA-A receptor agonist .
Experimental
Matched Iupac: … 5-({[7-cyclobutyl-3-(2,6-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]oxy}methyl)-1-methyl-1H …
Matched Description: … MRK-409 is a GABA-A receptor agonist [A31972]. …
2,6-dicarboxynaphthalene is a solid. This compound belongs to the naphthalenecarboxylic acids. These are compounds containing a napthalene moiety with a ring carbon which bears a carboxylic acid group. This drug targets the proteins hemoglobin subunit alpha and hemoglobin subunit beta.
Experimental
Matched Description: … These are compounds containing a napthalene moiety with a ring carbon which bears a carboxylic acid group ... 2,6-dicarboxynaphthalene is a solid. This compound belongs to the naphthalenecarboxylic acids. …
Experimental
Matched Name: … (E)-3-(5((5-(4-CHLOROPHENYL)FURAN-2-YL)METHYLENE)-4-OXO-2-THIOXOTHIAZOLIDIN-3-YL)PROPANOIC ACID …
Matched Iupac: … 3-[(5E)-5-{[5-(4-chlorophenyl)furan-2-yl]methylidene}-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]propanoic …
Experimental
Matched Name: … METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE …
Matched Iupac: … methyl 3-chloro-2-{2-[(2,5-dihydroxy-4-methoxyphenyl)carbamoyl]ethyl}-4,6-dihydroxybenzoate …
Experimental
Matched Name: … 2-methyl-3,5,7,8-tetrahydro-4H-thiopyrano[4,3-d]pyrimidin-4-one …
Matched Iupac: … 2-methyl-3H,4H,5H,7H,8H-thiopyrano[4,3-d]pyrimidin-4-one …
Experimental
Matched Name: … 3-FLUORO-4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME …
Matched Iupac: … (E)-[(3-fluoro-4-hydroxyphenyl)methylidene]amino cyclohexanecarboxylate …
Experimental
Matched Name: … 2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL …
Matched Iupac: … (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(octylsulfanyl)oxane-3,4,5-triol …
XMT-2056 is a HER2-targeted antibody-drug conjugate (ADC) consisting of a HER2-targeted antibody conjugated with a stimulator of interferon genes (STING) agonist payload.
Investigational
Matched Description: … XMT-2056 is a HER2-targeted antibody-drug conjugate (ADC) consisting of a HER2-targeted antibody conjugated ... with a stimulator of interferon genes (STING) agonist payload. …
Experimental
Matched Name: … 5-Imino-4-(2-trifluoromethyl-phenylazo)-5H-pyrazol-3-ylamine …
Matched Iupac: … 4-{2-[2-(trifluoromethyl)phenyl]hydrazin-1-ylidene}-4,5-dihydro-3H-pyrazole-3,5-diimine …
Dimethylcurcumin is a synthetic chemical compound that is loosely based on a compound found in curcumin. It is a novel anti-androgen that enhances androgen receptor degradation.
Investigational
Matched Iupac: … (1E,4Z,6E)-1,7-bis(3,4-dimethoxyphenyl)-5-hydroxyhepta-1,4,6-trien-3-one …
Matched Description: … Dimethylcurcumin is a synthetic chemical compound that is loosely based on a compound found in curcumin ... It is a novel anti-androgen that enhances androgen receptor degradation. …
Cemdisiran is under investigation in clinical trial NCT03841448 (A Study of Cemdisiran in Adults With Immunoglobulin a Nephropathy (Igan)).
Investigational
Matched Description: … Immunoglobulin a Nephropathy (Igan)). ... Cemdisiran is under investigation in clinical trial NCT03841448 (A Study of Cemdisiran in Adults With …
Sevasemten is under investigation in clinical trial NCT05291091 (Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)).
Investigational
Matched Synonyms: … 2-[(5-fluoropyridin-3-yl)methyl]-6-[2-(2,2,2- trifluoroethoxy)pyrimidin-5-yl]pyridazin-3(2H)-one …
Matched Description: … Sevasemten is under investigation in clinical trial NCT05291091 (Phase 2 Study of EDG-5506 in Becker …
SIG-007 is a gene therapy that consists of cells that are genetically modified with a non-viral vector to express human alpha-galactosidase A. Developed by Sigilon Therapeutics, t is being investigated for the treatment of Fabry Disease.
Investigational
Matched Description: … SIG-007 is a gene therapy that consists of cells that are genetically modified with a non-viral vector ... to express human alpha-galactosidase A. …
Leptazoline C is a polar oxazoline from the Cyanobacterium Leptolyngbya sp. Also see Leptazoline A, Leptazoline B, and Leptazoline D.
Experimental
Matched Iupac: … (3R)-3-hydroxy-3-[(4S,5S)-2-(2-hydroxyphenyl)-5-methyl-4,5-dihydro-1,3-oxazol-4-yl]propanoic acid …
Matched Description: … Also see [Leptazoline A], [Leptazoline B], and [Leptazoline D]. ... Leptazoline C is a polar oxazoline from the Cyanobacterium Leptolyngbya sp. …
Leptazoline D is a polar oxazoline from the Cyanobacterium Leptolyngbya sp. Also see Leptazoline A, Leptazoline B, and Leptazoline C.
Experimental
Matched Iupac: … (2S,3S)-N-(1,3-dihydroxypropan-2-yl)-2,3-dihydroxy-3-[(4S,5S)-2-(2-hydroxyphenyl)-5-methyl-4,5-dihydro …
Matched Description: … Also see [Leptazoline A], [Leptazoline B], and [Leptazoline C]. ... Leptazoline D is a polar oxazoline from the Cyanobacterium Leptolyngbya sp. …
Efinopegdutide is under investigation in clinical trial NCT03606057 (A Study to Investigate the Effect of JNJ-64565111 on Cardiac Repolarization (Corrected QT Interval) Compared With Placebo in Healthy Adults: a Thorough ECG Study Employing Placebo, JNJ-64565111, and a Positive Control (Moxifloxacin)).
Investigational
Matched Description: … Thorough ECG Study Employing Placebo, JNJ-64565111, and a Positive Control (Moxifloxacin)). ... Efinopegdutide is under investigation in clinical trial NCT03606057 (A Study to Investigate the Effect ... 64565111 on Cardiac Repolarization (Corrected QT Interval) Compared With Placebo in Healthy Adults: a
VTX-801 is a replication-deficient recombinant adeno-associated viral vector (rAAV) consisting of an AAV liver tropic capsid containing a single-stranded DNA genome carrying a shortened version of the ATP7B gene (ATP7B-minigene). It is being investigated in Wilson Disease.
Investigational
Matched Description: … AAV liver tropic capsid containing a single-stranded DNA genome carrying a shortened version of the ATP7B ... VTX-801 is a replication-deficient recombinant adeno-associated viral vector (rAAV) consisting of an …
Mepindolol is a 2-methyl derivative of pindolol. It is a beta blocker.
Experimental
Matched Iupac: … 1-[(2-methyl-1H-indol-4-yl)oxy]-3-[(propan-2-yl)amino]propan-2-ol …
Matched Description: … Mepindolol is a 2-methyl derivative of pindolol. It is a beta blocker. …
Experimental
Matched Name: … N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide …
Matched Iupac: … N-tert-butyl-4-{5-[(pyridin-2-yl)amino]quinolin-3-yl}benzene-1-sulfonamide …
Ostrea edulis shell is an animal extract used in some OTC (over-the-counter) products. It is not an approved drug.
Experimental
Experimental
Investigational
Matched Iupac: … (2R,3R)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol …
Matched Categories: … Heterocyclic Compounds, 1-Ring ... Heterocyclic Compounds, 2-Ring …
Flurothyl is a convulsant primarily used in experimental animals. It was formerly used to induce convulsions as a alternative to electroshock therapy.
Withdrawn
Matched Iupac: … 1,1,1-trifluoro-2-(2,2,2-trifluoroethoxy)ethane …
Matched Description: … Flurothyl is a convulsant primarily used in experimental animals. ... It was formerly used to induce convulsions as a alternative to electroshock therapy. …
Furafylline is a derivative of methylxanthine derivative. It was developed on the context of asthma as a long-acting alternative for theophylline.
Experimental
Matched Iupac: … 4-(5-{7-azabicyclo[2.2.1]heptan-2-yl}-2-fluoropyridin-3-yl)benzonitrile …
Matched Description: … Furafylline is a derivative of methylxanthine derivative. ... It was developed on the context of asthma as a long-acting alternative for [theophylline]. …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Developed by Sanofi-Aventis (formerly Sanofi-Synthelabo), osanetant (SR-142801) is an NK3 receptor antagonist which was under development for the treatment of schizophrenia and other Central Nervous System (CNS) disorders. In a review of its R&D portfolio, the company announced in August 2005 that it would cease any further development of osanetant....
Investigational
Matched Iupac: … N-(1-{3-[(3R)-1-benzoyl-3-(3,4-dichlorophenyl)piperidin-3-yl]propyl}-4-phenylpiperidin-4-yl)-N-methylacetamide …
Matched Description: … In a review of its R&D portfolio, the company announced in August 2005 that it would cease any further …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Displaying drugs 13076 - 13100 of 13918 in total